Physician profile
Eric Shrader Frechette
NPI 1457557910
$26,342.36
in general payments reported to CMS, 2019-2025
63 companies · $4,880 in 2025
The $4,880 reported for 2025 was more than what 85% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,238 · 2020: $2,881 · 2021: $3,753 · 2022: $3,820 · 2023: $3,611 · 2024: $4,160 · 2025: $4,880.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $191 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $25.06 · Travel and Lodging: $6.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,429.35 |
| Education | $190.68 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $25.06 |
| Travel and Lodging | $6.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $4,980.57 | 2019-2025 | Zilbrysq, Briviact, Rystiggo |
| Teva Pharmaceuticals USA, INC. | $1,542.96 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Sk Life Science, INC. | $1,505.34 | 2020-2025 | Xcopri |
| Abbvie INC. | $1,309.44 | 2021-2025 | |
| Neurocrine Biosciences, INC. | $1,241.21 | 2019-2025 | Ingrezza |
| Lundbeck LLC | $1,029.33 | 2019-2025 | Rexulti, Vyepti |
| Lilly USA, LLC | $1,029.20 | 2019-2025 | Kisunla, Amyvid, Emgality |
| Alexion Pharmaceuticals, INC. | $983.29 | 2019-2025 | Ultomiris |
| Greenwich Biosciences, INC. | $805.20 | 2019-2021 | |
| Eisai INC. | $757.70 | 2019-2025 | |
| Pfizer INC. | $736.40 | 2019-2025 | |
| Mdd US Operations, LLC | $665.00 | 2019-2025 | Gocovri, Gocovri |
| Amgen INC. | $564.51 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $516.90 | 2019-2022 | |
| Argenx US, INC. | $508.02 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $498.35 | 2021-2024 | |
| Otsuka America Pharmaceutical, INC. | $453.38 | 2020-2025 | Rexulti, Nuedexta |
| Acadia Pharmaceuticals INC | $431.53 | 2019-2025 | Nuplazid |
| Sunovion Pharmaceuticals INC. | $413.90 | 2019-2022 | |
| Biogen, INC. | $387.68 | 2019-2023 | Vumerity, Tysabri |
| Amneal Pharmaceuticals LLC | $385.64 | 2019-2025 | Crexont, Rytary |
| Harmony Biosciences LLC | $352.54 | 2020-2024 | Wakix |
| Neurelis, INC. | $339.20 | 2021-2025 | Valtoco |
| Kyowa Kirin, INC. | $311.38 | 2021-2024 | Nourianz |
| Takeda Pharmaceuticals U.S.A., INC. | $307.37 | 2019-2024 | Gammagard, Hyqvia |
| Allergan, INC. | $291.13 | 2019-2020 | |
| Corium, LLC | $250.31 | 2022-2023 | Adlarity |
| Medtronic, INC. | $242.29 | 2021 | |
| Catalyst Pharmaceuticals, INC. | $228.79 | 2020-2025 | Fycompa |
| Abbott Laboratories | $226.74 | 2020-2025 | Infinity |
| Astrazeneca Pharmaceuticals LP | $223.46 | 2021-2024 | Wainua |
| Grifols USA, LLC | $209.05 | 2019-2024 | Gamunex-C |
| Axsome Therapeutics, INC. | $205.33 | 2025 | Symbravo, Auvelity |
| Forte Bio-Pharma LLC | $168.44 | 2025 | Tanlor |
| Novartis Pharmaceuticals Corporation | $164.89 | 2019-2021 | |
| Celgene Corporation | $160.16 | 2021-2024 | Zeposia |
| Biohaven Pharmaceutical Holding Company LTD. | $159.60 | 2022 | |
| Acorda Therapeutics, INC | $148.26 | 2021-2023 | Ampyra, Inbrija |
| Avanir Pharmaceuticals, INC. | $148.24 | 2019-2021 | |
| Csl Behring | $141.11 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $128.61 | 2021 | |
| Livanova USA, INC. | $106.42 | 2019-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Merz Pharmaceuticals, LLC | $97.69 | 2024-2025 | Inbrija, Xeomin |
| Travere Therapeutics, INC. | $95.90 | 2019-2023 | Cholbam |
| Upsher-Smith Laboratories LLC | $90.92 | 2020-2021 | |
| Alnylam Pharmaceuticals INC. | $79.14 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $73.42 | 2023 | Aptiom |
| Octapharma USA, INC. | $72.10 | 2024-2025 | Panzyga |
| Emd Serono, INC. | $65.75 | 2019 | |
| Genzyme Corporation | $59.58 | 2019-2023 | |
| Bausch Health US, LLC | $58.96 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $52.03 | 2020-2021 | |
| Ge Healthcare | $50.98 | 2025 | |
| Janssen Pharmaceuticals, INC | $45.04 | 2020-2021 | |
| Zogenix INC. | $39.92 | 2020-2021 | |
| Aquestive Therapeutics, INC. | $37.07 | 2020-2021 | |
| Vertical Pharmaceuticals, LLC | $33.49 | 2019 | |
| Zyla Life Sciences, INC. | $31.95 | 2019 | |
| Arbor Pharmaceuticals, INC. | $29.86 | 2020-2021 | |
| Grt US Holding, INC. | $22.91 | 2021 | |
| Adamas Pharmaceuticals, INC. | $15.89 | 2019 | |
| Ceribell, INC. | $15.76 | 2022 | |
| Azurity Pharmaceuticals, INC. | $15.13 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Frechette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.